Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 14, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nuvalent, Inc.
| 2.5K |
—
|
—
|
∞
| 2.5K |
Jun 12
| |||||||
Mersana Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 11
| |||||||
Nuvalent, Inc.
| -880.00K |
$72.77 | -$64,035,958.59 | -24.60% | 2.7M |
Mar 27
| |||||||
Dynavax Technologies Corp
| -1.50M |
$14.39 | -$21,585,000.00 | -62.11% | 915K |
Aug 8
| |||||||
Nuvalent, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Dynavax Technologies Corp
| -500.00K |
$12.68 | -$6,340,000.00 | -17.15% | 2.42M |
Jun 14
| |||||||
Mersana Therapeutics, Inc.
| 14.47K |
—
|
—
|
∞
| 14.47K |
Jun 8
| |||||||
Dynavax Technologies Corp
| 5.36K |
—
|
—
| +100.00% | 10.71K |
May 26
| |||||||
Dynavax Technologies Corp
| -1.00M |
$10.55 | -$10,550,000.00 | -25.54% | 2.92M |
May 18
| |||||||
Dynavax Technologies Corp
| -1.50M |
$11.60 | -$17,400,000.00 | -27.70% | 3.92M |
Dec 6
| |||||||
Nuvalent, Inc.
| 149.25K |
$33.50 | $4,999,975.50 | +4.35% | 3.58M |
Nov 3
| |||||||
Dynavax Technologies Corp
| -3.00M |
$14.68 | -$44,040,000.00 | -35.65% | 5.42M |
Aug 15
| |||||||
Nuvalent, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 16
| |||||||
Mersana Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Mersana Therapeutics, Inc.
| 95.52K |
$3.27 | $311,958.27 | +1.11% | 8.66M |
May 31 - Jun 2
| |||||||
Dynavax Technologies Corp
|
0
|
—
|
—
|
—
|
0
|
May 26
| |||||||
Mersana Therapeutics, Inc.
| 265.15K |
$3.22 | $854,174.63 | +3.19% | 8.57M |
May 24 - May 26
| |||||||
Mersana Therapeutics, Inc.
| 215.6K |
$3.46 | $746,437.29 | +2.67% | 8.3M |
May 19 - May 23
| |||||||
Mersana Therapeutics, Inc.
| 350K |
$3.25 | $1,137,659.94 | +4.52% | 8.09M |
May 16 - May 18
| |||||||
Mersana Therapeutics, Inc.
| 617.28K |
$4.05 | $2,500,000.20 | +8.67% | 7.74M |
Apr 13
| |||||||
Mersana Therapeutics, Inc.
| 598.09K |
$4.18 | $2,499,879.86 | +9.17% | 7.12M |
Apr 12
| |||||||
Mersana Therapeutics, Inc.
| 1.14M |
$4.42 | $5,022,724.46 | +21.10% | 6.52M |
Feb 7
| |||||||
Mersana Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 3
| |||||||
Mersana Therapeutics, Inc.
| 815K |
$6.15 | $5,012,250.00 | +17.83% | 5.39M |
Dec 30
| |||||||
Mersana Therapeutics, Inc.
| 875K |
$5.75 | $5,031,250.00 | +23.68% | 4.57M |
Dec 29
| |||||||
Dynavax Technologies Corp
| -109.00K |
$16.22 | -$32,440,000.00 | -1.28% | 8.41M |
Aug 27
| |||||||
Dynavax Technologies Corp
| -1.00K |
$10.80 | -$24,300,000.00 | -0.01% | 8.52M |
Aug 9
| |||||||
Nuvalent, Inc.
| 3.43M |
$17.00 |
—
|
∞
| 3.43M |
Aug 2
| |||||||
Nuvalent, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 28
| |||||||
Nuvalent, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Mersana Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 11
| |||||||
Dynavax Technologies Corp
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Dynavax Technologies Corp
|
0
|
—
|
—
|
—
|
0
|
May 28
| |||||||
Mersana Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 15
| |||||||
Mersana Therapeutics, Inc.
| 250K |
$18.36 | $4,590,000.00 | +7.26% | 3.7M |
Jan 8 - Jan 12
| |||||||
Allena Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 17
| |||||||
Atea Pharmaceuticals, Inc.
| 5.62M |
$24.00 |
—
|
∞
| 5.62M |
Nov 3
| |||||||
Atea Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 29
| |||||||
Atea Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Bcls Acquisition Corp.
| 487.5K |
$10.00 | $4,875,000.00 |
∞
| 487.5K |
Oct 26
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.